www.magazine-industry-usa.com
22
'22
Written on Modified on
ZEISS News
ZEISS Announces U.S. FDA Clearance of the QUATERA 700, a Revolution in Phaco Technology
ZEISS Medical Technology has announced the U.S. Food and Drug Administration (FDA) has cleared the QUATERA® 700*, a revolution in phaco technology. It includes the ZEISS patented QUATTRO Pump® which delivers an exceptional level of chamber stability independent of intra-ocular pressure (IOP) and flow.
The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise.
“What excites me the most about the QUATERA 700 is the QUATTRO pump’s synchronized fluidics system and how I can have both the highest levels of efficiency, while maintaining an extremely stable chamber, independent of IOP,” said Sri Ganesh, MD, Chairman and Managing Director of Nethradhama Super Speciality Eye Hospital, Bangalore (India).
The ZEISS QUATERA 700 is designed to increase a surgeon’s workflow efficiency from the clinic to the operating room (OR), enabling one digitally integrated surgical workflow. It works as a single sterile OR dashboard integrating patient data from other systems and the microscope view, available in real-time for the OR staff.
“It’s great to see that ZEISS has added another critical piece to the cataract workflow, a digital solution that further enables us to become more efficient and effective during surgical procedures,” said Elizabeth Yeu, MD, Virginia Eye Consultants, Norfolk, Virginia (USA).
“Building on the company’s first-in-class medical technologies, ZEISS is committed to continuously expanding our innovative solutions,” said Dr. Markus Weber, President and CEO of Carl Zeiss Meditec AG. “Our investment in the latest digital technologies help make customers’ workflows more efficient by integrating solutions and improving clinical results.”
“ZEISS is committed to bringing our latest innovations to the United States, and the ZEISS QUATERA 700 is a great example of how integrated technology can drive efficiency in ophthalmology,” said Euan S. Thomson, PhD, President of Ophthalmic Devices and Head of the Digital Business Unit for Carl Zeiss Meditec. “Together with our ZEISS Medical Ecosystem and surgical planning software, we believe this fully connected and integrated approach will help set new standards for patient care and clinical management.”
www.zeiss.com
